RecruitingNot applicableNCT04520932

Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors

Studying Neuroendocrine tumor of pancreas

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institut Paoli-Calmettes
Principal Investigator
Fabrice CAILLOL, MD
Paoli Calmettes Institute
Intervention
Radiofrequency ablation(procedure)
Enrollment
82 enrolled
Eligibility
18-80 years · All sexes
Timeline
2021 – 2031

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04520932 on ClinicalTrials.gov

Other trials for Neuroendocrine tumor of pancreas

Additional recruiting or active studies for the same condition.

See all trials for Neuroendocrine tumor of pancreas →

← Back to all trials